36
Participants
Start Date
August 31, 2010
Primary Completion Date
November 30, 2014
Study Completion Date
September 30, 2015
AMG 102
AMG 102 will be administered as a continuous intravenous infusion by an infusion pump at 20 mg/kg every 2 weeks over 60 or 30 minutes.
Avastin
Avastin will be administered as a continuous intravenous infusion at 10 mg/kg every 2 weeks (6-week study cycle) over 60 or 30 minutes. Avastin will be given prior to AMG 102.
The Preston Robert Tisch Brain Tumor Center, Durham
Collaborators (1)
Katy Peters
OTHER
Amgen
INDUSTRY